Journal of Experimental & Clinical Cancer Research (Apr 2024)
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
- Baoyuan Zhang,
- Ning Li,
- Jiaming Gao,
- Yuxi Zhao,
- Jun Jiang,
- Shuang Xie,
- Cuiping Zhang,
- Qingyu Zhang,
- Leo Liu,
- Zaiqi Wang,
- Dongmei Ji,
- Lingying Wu,
- Ruibao Ren
Affiliations
- Baoyuan Zhang
- State Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Ning Li
- Department of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College
- Jiaming Gao
- State Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Yuxi Zhao
- Department of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College
- Jun Jiang
- InxMed (Shanghai) Co., Ltd
- Shuang Xie
- InxMed (Shanghai) Co., Ltd
- Cuiping Zhang
- Department of Pathology, Yantai Afliated Hospital of Binzhou Medical University
- Qingyu Zhang
- Laboratory of Obstetrics and Gynecology, Afliated Hospital of Guangdong Medical University
- Leo Liu
- InxMed (Shanghai) Co., Ltd
- Zaiqi Wang
- InxMed (Shanghai) Co., Ltd
- Dongmei Ji
- Department of Medical Oncology, Fudan University Shanghai Cancer Center
- Lingying Wu
- Department of Gynecologic Oncology, National Cancer Center, National Clinical Research Center for Cancer/Cancer Hospital, Chinses Academy of Medical Sciences and Peking Union Medical College
- Ruibao Ren
- State Key Laboratory for Medical Genomics, Collaborative Innovation Center of Hematology, Shanghai Institute of HematologyNational Research Center for Translational Medicine Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- DOI
- https://doi.org/10.1186/s13046-024-03033-8
- Journal volume & issue
-
Vol. 43,
no. 1
pp. 1 – 1
Abstract
No abstracts available.